ZA963754B - Antifungal composition. - Google Patents

Antifungal composition.

Info

Publication number
ZA963754B
ZA963754B ZA9603754A ZA963754A ZA963754B ZA 963754 B ZA963754 B ZA 963754B ZA 9603754 A ZA9603754 A ZA 9603754A ZA 963754 A ZA963754 A ZA 963754A ZA 963754 B ZA963754 B ZA 963754B
Authority
ZA
South Africa
Prior art keywords
pct
date nov
azole
sec
antifungal composition
Prior art date
Application number
ZA9603754A
Other languages
English (en)
Inventor
Josef Gottfried Meingassner
Neil Stewart Ryder
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA963754B publication Critical patent/ZA963754B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
ZA9603754A 1995-05-12 1996-05-10 Antifungal composition. ZA963754B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9509631.9A GB9509631D0 (en) 1995-05-12 1995-05-12 Antifungal combination

Publications (1)

Publication Number Publication Date
ZA963754B true ZA963754B (en) 1997-11-10

Family

ID=10774361

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9603754A ZA963754B (en) 1995-05-12 1996-05-10 Antifungal composition.

Country Status (26)

Country Link
US (1) US5985906A (fi)
EP (1) EP0824350B1 (fi)
JP (1) JPH11504931A (fi)
KR (1) KR100443535B1 (fi)
CN (1) CN1100539C (fi)
AT (1) ATE246504T1 (fi)
AU (1) AU712914B2 (fi)
CA (1) CA2219651C (fi)
CY (1) CY2496B1 (fi)
CZ (1) CZ291144B6 (fi)
DE (1) DE69629367T2 (fi)
DK (1) DK0824350T3 (fi)
ES (1) ES2205042T3 (fi)
FI (1) FI120079B (fi)
GB (1) GB9509631D0 (fi)
HK (1) HK1016064A1 (fi)
HU (1) HU224920B1 (fi)
IL (2) IL118219A (fi)
MX (1) MX9708699A (fi)
NO (1) NO317030B1 (fi)
PL (1) PL322749A1 (fi)
PT (1) PT824350E (fi)
SK (1) SK150797A3 (fi)
TW (1) TW464492B (fi)
WO (1) WO1996035423A1 (fi)
ZA (1) ZA963754B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
WO2001014387A1 (en) * 1999-08-24 2001-03-01 Ariad Gene Therapeutics, Inc. 28-epirapalogs
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
BRPI0418589A (pt) 2003-12-08 2008-01-29 Bentley Pharmaceuticals Inc composições farmacêuticas e métodos para tratamento por insulina
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
RU2396955C2 (ru) 2005-04-07 2010-08-20 Тояма Кемикал Ко., Лтд. Фармацевтическая комбинация и способ применения противогрибкового средства в комбинации
PL2070536T3 (pl) 2006-10-06 2012-06-29 Toyama Chemical Co Ltd Kompozycja farmaceutyczna zawierająca pochodną fenyloamidyny oraz sposób stosowania kompozycji farmaceutycznej w kombinacji ze środkiem przeciwgrzybiczym
WO2008073863A2 (en) * 2006-12-08 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
WO2009089549A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
WO2014200659A1 (en) 2013-06-11 2014-12-18 Clontech Laboratories, Inc. Protein enriched microvesicles and methods of making and using the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
JP2581707B2 (ja) * 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
CA2016738A1 (en) * 1989-06-08 1990-12-08 Philippe Guerry Substituted aminoalkylbenzene derivatives
JPH0338522A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
JPH0338521A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
CA2044533A1 (en) * 1990-06-29 1991-12-30 Philippe Guerry Substituted aminoalkylbiphenyl derivatives
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JP3038522U (ja) 1996-12-05 1997-06-20 秀俊 筬 カード型紙箱ポプリ
JP3038521U (ja) 1996-12-05 1997-06-20 啓次 小峰 排泄物一時保持具用の水溶繊維製ステック状吸液材

Also Published As

Publication number Publication date
EP0824350A1 (en) 1998-02-25
MX9708699A (es) 1998-02-28
WO1996035423A1 (en) 1996-11-14
TW464492B (en) 2001-11-21
AU712914B2 (en) 1999-11-18
PT824350E (pt) 2003-12-31
DE69629367T2 (de) 2004-06-09
CY2496B1 (en) 2005-09-02
SK150797A3 (en) 1998-05-06
NO317030B1 (no) 2004-07-26
CZ291144B6 (cs) 2002-12-11
FI973812A (fi) 1997-11-11
HUP9801140A3 (en) 2000-07-28
GB9509631D0 (en) 1995-07-05
CA2219651A1 (en) 1996-11-14
CN1184427A (zh) 1998-06-10
US5985906A (en) 1999-11-16
KR100443535B1 (ko) 2004-12-17
DE69629367D1 (de) 2003-09-11
PL322749A1 (en) 1998-02-16
KR19990014708A (ko) 1999-02-25
NO975134L (no) 1997-11-07
NO975134D0 (no) 1997-11-07
CZ354797A3 (cs) 1998-02-18
FI120079B (fi) 2009-06-30
AU5818396A (en) 1996-11-29
IL118219A0 (en) 1996-09-12
HUP9801140A2 (hu) 1999-01-28
IL118219A (en) 2001-08-26
CA2219651C (en) 2007-03-27
CN1100539C (zh) 2003-02-05
ATE246504T1 (de) 2003-08-15
HK1016064A1 (en) 1999-10-29
HU224920B1 (en) 2006-04-28
JPH11504931A (ja) 1999-05-11
EP0824350B1 (en) 2003-08-06
FI973812A0 (fi) 1997-09-26
ES2205042T3 (es) 2004-05-01
DK0824350T3 (da) 2003-11-03

Similar Documents

Publication Publication Date Title
HK1016064A1 (en) Antifungal composition
LU93229I2 (fr) "pitolisant et ses sels pharmaceutiquement acceptables, tel que chlorhydrate"
AP9701018A0 (en) Squalene synthetase inhibitor compounds.
IL139080A0 (en) Btx inhibitors and methods for their indentification and use
PL361233A1 (en) Efficient ligand-mediated ullmann coupling of anilines and azoles
ATE222100T1 (de) Amidino-derivate nützlich als no synthase-hemmer
GB9317636D0 (en) Use of dexmedetomidine
GR3030626T3 (en) 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
PT1235579E (pt) Composicoes farmaceuticas contendo trimegestona
BG100248A (en) Squalene synthetase inhibitors
NO981019L (no) Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer
AU2001274786A1 (en) Method for the treatment of overactive bladder
WO2001004354A3 (en) Use of ras inhibitors of inhibiting muscle atrophy
EP0566666A4 (en) Novel glucohydrolase inhibitors useful as antidiabetic agents
NO975084D0 (no) Bakteriostatisk preparat og dets anvendelse i metallbearbeidingsfluider
PL323305A1 (en) Applications of allyl amines
GR3035459T3 (en) Steel, method for its manufacture, its use and product made from steel
MX9603305A (es) Proceso mejorado para la ruptura de emulsiones de aceite.
ITMI20000908A0 (it) Metodo e sistema per l'assicurazione di un investimento in titoli azionari e similari.
UA42111C2 (uk) Засіб для прихованого маркування небіологічних об'єктів
MX9709450A (es) Piridiniminil-1,2-benzoisoxazoles y -benzoisotiazoles como agentes antipsicoticos.
PL322847A1 (en) Condensed b-carbolins